Innovative and Trendy: New E-cigarette Products in the UK

Feb.08.2025
Innovative and Trendy: New E-cigarette Products in the UK
New e-cigarette products flood the UK market during Chinese New Year, offering innovative designs and improved user experience.

Special announcement:

This article is intended for internal industry communication only and does not make any recommendations for specific brands or products.

The images displayed in this article are used solely to describe facts and are not intended as advertisements for any products.

This article is prohibited for minors to access.


 

During the Spring Festival, the e-cigarette market in the UK saw a constant influx of new products from various major brands, introducing innovative and differentiated products. These new products have significantly improved in design, functionality, and user experience.

 

Two new products were discovered to still favor the "2+10" design as a mainstream in the market, while dual flavor e-cigarettes continue to be popular. (Recommended reading: "New Year Inventory | 5 e-cigarettes released in the US market, adjustable and personalized becoming mainstream")

 

2+10" product

 

E-cigarette brands IVG and Vapes Bars have launched new models, the "2+10" e-cigarettes IVG Pro 12 and Ghost Pro 6000+. Both products feature a 2+10 design, in compliance with TPD standards, and come equipped with large capacity batteries.

 

Specifically, the main product parameters of IVG Pro 12 and Ghost Pro 6000+ are as shown in the following table:

 

Dual-flavored e-cigarette.

 

Recently, e-cigarette retailers in the UK have introduced two new dual-flavored e-cigarettes on their websites: the LUV ME 30K and the ENJOY Ultra 18K. Both products are equipped with two flavors of e-liquid that can be switched by changing the mouthpiece.

 

To be more specific, the main product specifications for LUV ME 30K and ENJOY Ultra 18K are as follows in the table below:

 

Innovative and Trendy: New E-cigarette Products in the UK
The main product parameters of LUV ME 30K and ENJOY Ultra 18K are as follows | Design: 2FIRSTS

 

Innovative e-cigarette

 

E-cigarette brand Lost Mary has launched a modular design product, Lost Mary Nera 30K, in the UK market. The product features a 2+10 design. Additionally, the smartphone e-cigarette Ice Dragon 40K has also been introduced in the UK market.

 

Looking specifically at the main product specifications for Lost Mary Nera 30K and Ice Dragon 40K, they are as shown in the table below:

 

Innovative and Trendy: New E-cigarette Products in the UK
Lost Mary Nera 30K and Ice Dragon 40K main product parameters | Diagram: 2FIRSTS

 

 


2Firsts will continue to monitor the performance and market trends of e-cigarette products globally, providing the public with accurate and authoritative industry information.

 

2FIRSTS, a product column, focuses on providing readers with the latest information on new products in the tobacco industry. In order to gather and share firsthand information from the industry more widely, 2FIRSTS welcomes readers to submit articles and share the latest products in the e-cigarette field with us.

 

If you have any unique insights or information, feel free to contact us anytime via email at info@2firsts.com or reach out to 2Firsts CEO Alan Zhao on LinkedIn.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11
Russia Adds Vapes to “Strategic Goods” List, Illegal Cross-Border Trade Faces Up to Five Years in Prison
Russia Adds Vapes to “Strategic Goods” List, Illegal Cross-Border Trade Faces Up to Five Years in Prison
Russia will place e-cigarettes and related nicotine products under its “strategic goods” framework from August 20, 2026. According to TVP World’s report published on August 19, the newly listed items include e-cigarettes, electronic smoking devices, vape liquids and nicotine salts. Individuals who illegally move these products across Russia’s customs border or its state border with other Eurasian Economic Union (EAEU) members could face up to five years in prison if shipment values exceed 100,000 rubles (about €1,000), provided all elements of a criminal offence are established.
Aug.20
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company has begun selling four flavored Vuse Pro pods — Peach, Berry, Watermelon and Fresh Mint — in Ohio and selected other U.S. markets. According to the Vuse U.S. FAQ, Vuse Pro contains approximately 5.0% nicotine by weight, and Vuse Pro pre-filled pods are intended for use with Vuse Alto devices. Reynolds told 2Firsts that product labeling lists an e-liquid capacity of 2.0 mL per pod. The Vuse Alto Power Unit received FDA marketing authorization in 2024, while the new Vuse Pro pods themselves have not received marketing granted orders. The rollout follows the FDA’s May 2026 revision of enforcement priorities for certain unauthorized vaping products with qualifying pending applications.
BAT
Sep.10
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
JTI Research Finds 31% of UK Respondents Offered Illicit Tobacco, While 63% of Ennis Packs Lack Duty Marks
Multiple JTI-backed studies in the UK and Ireland indicate that illicit tobacco remains visible across consumer interactions and local markets. In the UK, JTI research found that 31% of respondents said they had been offered illicit tobacco products. In Ireland’s Ennis area, a JTI-commissioned empty pack survey found that 63% of sampled cigarette packs did not carry Irish duty-paid markings. The findings come from industry research rather than official government estimates of illicit tobacco market size, but highlight continued concerns among regulators, legitimate retailers and tobacco companies over illicit trade.
Aug.19
From Nicotine Pouches to Soft Candy Forms: China Tobacco Hubei explores adjustable-release oral nicotine products
From Nicotine Pouches to Soft Candy Forms: China Tobacco Hubei explores adjustable-release oral nicotine products
China-based China Tobacco Hubei Industrial Co., Ltd. has filed a patent application covering an oral nicotine product and its preparation method. The patent proposes a soft candy-shaped oral nicotine product containing nicotine ingredients, gelling agents, sweeteners and alkaline pH regulators. Through formulation adjustments and homogeneous or dual-layer structures, the technology aims to achieve different nicotine release profiles. The filing reflects exploration of new oral nicotine product formats and controlled nicotine delivery approaches.
Aug.06